These results suggest that modulating the redox environment and ROS levels through MCJ silencing or ROS scavenging with MitoQ can significantly impact ccRCC progression and metastasis, potentially by affecting the secretion of legumain. This evidence concerns the gene DNAJC15 and nonpapillary renal cell carcinoma.